Venture Funding Deals: ADC Therapeutics, Unity Biotech Raise $100m-Plus

11 Nov 2016

• By Deanna Kamienski, Beth Allan, Maureen Riordan, and Steven Muntner

ADC Therapeutics and Unity Biotechnology close $100m-plus VC rounds, while Carrick comes close with a $95m debut. Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced in September and October 2016.

Cancer company Achilles Therapeutics Ltd. has launched with a £13.2m ($16.9m) Series A round provided by CRT Pioneer Fund, UCL Technology Fund, and company founders Syncona LLP, Cancer Research UK’s Cancer Research Technology (CRT), UCL Business and the Francis Crick Institute. (Oct.)

Achilles will design cancer therapies using technology exclusively licensed from Cancer Research UK pertaining to truncal neo-antigens, which are protein...